SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy.

Saved in:
Bibliographic Details
Title: SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy.
Authors: Drilon A; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Sharma MR; START Midwest, Grand Rapids, Michigan., Johnson ML; Sarah Cannon Research Institute, Nashville, Tennessee., Yap TA; The University of Texas MD Anderson Cancer Center, Houston, Texas., Gadgeel S; Henry Ford Cancer Center/Henry Ford Health, Detroit, Michigan., Nepert D; Pfizer Boulder Research Unit, Boulder, Colorado., Feng G; Early Clinical Development, Pfizer, Inc., Cambridge, Massachusetts., Reddy MB; Pfizer Boulder Research Unit, Boulder, Colorado., Harney AS; Pfizer Boulder Research Unit, Boulder, Colorado., Elsayed M; Pfizer Boulder Research Unit, Boulder, Colorado., Cook AW; Pfizer Boulder Research Unit, Boulder, Colorado., Wong CE; Pfizer Boulder Research Unit, Boulder, Colorado., Hinklin RJ; Pfizer Boulder Research Unit, Boulder, Colorado., Jiang Y; Pfizer Boulder Research Unit, Boulder, Colorado., Brown EN; Pfizer Boulder Research Unit, Boulder, Colorado., Neitzel NA; Pfizer Boulder Research Unit, Boulder, Colorado., Laird ER; Pfizer Boulder Research Unit, Boulder, Colorado., Wu WI; Pfizer Boulder Research Unit, Boulder, Colorado., Singh A; Pfizer Boulder Research Unit, Boulder, Colorado., Wei P; Pfizer Oncology Research and Development, La Jolla, California., Ching KA; Pfizer Oncology Research and Development, La Jolla, California., Gaudino JJ; Pfizer Boulder Research Unit, Boulder, Colorado., Lee PA; Pfizer Boulder Research Unit, Boulder, Colorado., Hartley DP; Pfizer Boulder Research Unit, Boulder, Colorado., Rothenberg SM; Pfizer Boulder Research Unit, Boulder, Colorado.; Pfizer Oncology Research and Development, La Jolla, California.
Source: Cancer discovery [Cancer Discov] 2023 Aug 04; Vol. 13 (8), pp. 1789-1801.
Publication Type: Editorial; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2159-8290
DOI:10.1158/2159-8290.CD-23-0361